The complex sulfation motifs of heparan sulfate glycosaminoglycans (HS GAGs) play critical roles in many important biological processes.However,anunderstanding of their specific functions has been hampered by an inability to synthesize large numbers of diverse,yet defined, HS structures. Herein, we describe an ew approach to access the four core disaccharides required for HS/heparin oligosaccharide assembly from natural polysaccharides.T he use of disaccharides rather than monosaccharides as minimal precursors greatly accelerates the synthesis of HS GAGs,p roviding key disaccharide and tetrasaccharide intermediates in about half the number of steps compared to traditional strategies.R apid access to such versatile intermediates will enable the generation of comprehensive libraries of sulfated oligosaccharides for unlocking the "sulfation code" and understanding the roles of specific GAGs tructures in physiology and disease.
Introduction
Heparan sulfate (HS) glycosaminoglycans (GAGs) are linear, sulfated polysaccharides that mediate aw ide range of important biological and disease processes,i ncluding cell growth and proliferation, brain development, immune regulation, viral invasion, angiogenesis,a nd tumor metastasis. [1] Thed iverse activities of GAGs stem largely from their complex sulfation patterns,which facilitate the interactions of GAGs with hundreds of different proteins. [2] HS chains are composed of repeating disaccharide units of glucosamine (GlcN) joined via a-1,4-linkages to either d-glucuronic acid (GlcA) or l-iduronic acid (IdoA;F igure 1). Sulfation at the N-, 6-O-, and 3-O-positions of GlcN and the 2-O-position of GlcA or IdoA produces many different sulfation patterns that are tissue-specific,age-specific, and tightly regulated in vivo. [3] Indeed, as imple HS tetrasaccharide has the potential to display 1024 different sulfation sequences,h ighlighting the intriguing capacity of GAGs for molecular recognition. However,t his chemical complexity has limited access to well-defined structures and hampered efforts to understand the biology of HS GAGs and to develop HS-based therapeutics.
Synthetic chemistry provides an elegant solution to this challenge.Anotable example is the heparin-based pentasaccharide drug fondaparinux, which is approved for the treatment of deep vein thrombosis.T he synthesis of various HS analogues was critical for identifying ar are 3-O-sulfated sequence that regulates antithrombin III activity. [1a] However, despite remarkable progress over the past two decades, [4] the synthesis of HS oligosaccharides remains as ignificant challenge.Only asmall subset of the potential sulfation motifs has been generated, resulting in ap aucity of structure-function information and hindering broad application of the compounds to biology.
Am ajor roadblock lies in the preparation of suitable HS building blocks.T he synthesis of selectively protected IdoAand GlcA-containing disaccharides,w hich are traditionally derived from monosaccharide precursors,usually requires 18-29 steps each, depending on the complexity of the protecting groups (see the Supporting Information, Figure S1 , for representative literature examples). This is due to al ack of commercial sources for l-iduronic acid/l-idose,aswell as the need for stereoselective formation of glycosidic bonds and elaborate protecting group strategies to direct regioselective sulfation. Another major roadblock is the lack of universal building blocks for the synthesis of HS GAGs.I deally, virtually any sulfation motif could be obtained from as mall set of building blocks.T he lengthy,l aborious processes required and the absence of universal building blocks have fundamentally limited the ability to produce large,c omprehensive libraries of HS oligosaccharides.T od ate,s ulfated libraries of compounds representing all possible sulfation motifs have only been attainable in the case of HS disaccharides. [4o] Herein, we report an ovel, expedient approach to synthesize the four core disaccharides required for HS/ heparin oligosaccharide assembly.W es how that these key disaccharides can be obtained on al arge scale from readily available natural polysaccharides and efficiently converted into versatile synthetic intermediates.I mportantly,b ye mploying disaccharides rather than monosaccharides as the minimum precursors,t his approach eliminates half of the challenging glycosidic bond-forming reactions and significantly reduces the total number of steps.T he new methods described herein should greatly streamline the synthesis of HS oligosaccharides and accelerate the production of diverse collections of HS GAGs equences.
Results and Discussion
Naturally occurring heparin is an attractive starting material because it is commercially available (ca. $14 g À1 ) and produced on al arge scale for pharmaceutical use.W e envisioned that key IdoA-containing building blocks for HS/ heparin synthesis might be obtained through the controlled hydrolysis of heparin. However,h ydrolysis of heparin under basic conditions results in b-elimination to form unsaturated uronic acid moieties, [5] while nitrous acid mediated depolymerization of heparin is accompanied by deaminative ring contraction of GlcN. [6] Fortunately,elegant studies by Davidson and Meyer, [7] as well as Lopin and Jacquinet, [8] showed that chondroitin sulfate (CS) could be hydrolyzed using aqueous H 2 SO 4 to provide GlcA-N-acetylgalactosamine (GalNAc) disaccharides.S elective cleavage of the GalNAcÀ GlcA bond was presumably facilitated by neighboring group participation from the N-acetyl group of GalNAc.
Encouraged by these reports,w eg enerated N-acetylated (N-Ac) heparin by subjecting sodium heparinate (which is > 85 % N-sulfated) to N-desulfation and N-acetylation [9] and then explored the ability of various acids (e.g., H 2 SO 4 ,T FA, CuCl, TMSOTf, BF 3 Et 2 O, TfOH) to produce intact HS disaccharides.W ef ound that N-Ac-heparin was efficiently hydrolyzed to give disaccharides as the major product using 1m TfOH at 100 8 8Cf or approximately 6h (Scheme 1a nd Figure S2 ). Thec rude free disaccharide was then esterified using AcCl and MeOH, which also resulted in methylation of the anomeric hydroxy group.H ydrolysis of this methyl glycoside and acetylation of the free hydroxy groups using acetic anhydride,f ollowed by treatment with acetic anhydride/pyridine to effect N-acetylation, resulted in peracetylated disaccharide 1.
Unexpectedly,N MR structural analysis revealed that cleavage of the glycosidic bond had occurred predominantly at the reducing end of IdoA to give the GlcN-IdoA disaccharide.F ormation of the other disaccharide,I doA-GlcN,w as not observed by NMR spectroscopy,a lthough its presence was detected by hydrophilic interaction chromatography-Fourier transform mass spectrometry (HILIC-FTMS; Figure S2 ). These results suggest that the N-acetyl group of heparin does not significantly promote the reaction. As further confirmation that an N-acetyl group was not required, we performed the reaction directly on sodium heparinate.W e found that sodium heparinate was efficiently hydrolyzed using 2 m TfOH at 100 8 8C( Figure S3 ). Extensive optimization was conducted to maximize scalability and reproducibility. Starting from 25 go fn atural heparin, the key GlcN-IdoA disaccharide 1 was routinely obtained in aone-pot, four-step reaction sequence (single purification step) in 18 %o verall yield (4.4 g; Scheme 1a nd Table S1 ). Importantly,d irect Scheme 1. Synthesis of GlcN-IdoA and GlcA-GlcN building blocks from natural polysaccharides. TfOH = trifluoromethanesulfonic acid, Ac = acetyl, TfN 3 = trifluoromethanesulfonyla zide, DCM = dichloromethane, CbzCl = benzyl chloroformate. access to this disaccharide obviates the need to perform the notoriously challenging stereoselective 1,2-cis glycosylation reaction [10] to generate GlcN-a(1,4)-IdoA linkages.
Thea mino groups of HS/heparin are known to be acetylated, sulfated, or unmodified in vivo.T hus,t oe xpand the versatility of the method further,wesought to convert the N-acetamide of 1 into other synthetically useful functionalities.T reatment of the amine with TfN 3 ,K 2 CO 3 ,and ZnCl 2 after the esterification step,f ollowed by anomeric demethylation and peracetylation, resulted in smooth conversion into the desired GlcN 3 -IdoA disaccharide 1b in 20 %y ield over the four steps (Scheme 1). From 25 go fh eparin, 4.8 go f disaccharide 1b were obtained in the course of 3-4 days (Table S1 ), highlighting the scalability and practicality of the route.A lternatively,t he use of benzyl chloroformate introduced an N-Cbz protecting group in place of the N-acetyl group to give 1c in 8.5 %yield over the four steps.
We next investigated whether we could obtain GlcAcontaining disaccharides from heparosan, the biosynthetic precursor to heparin. Large-scale fermentation procedures have been developed for the purification of heparosan (> 100 g) from Escherichia coli K5. [11] We found that heparosan was efficiently hydrolyzed under slightly milder acidic conditions of 1m TfOH at 100 8 8C( Scheme 1a nd Figure S4 ). After esterification and peracetylation using similar conditions as before,t he GlcA-GlcN disaccharide 2 was obtained in 16 %o verall yield (4.9 g) over the four steps (single purification step) starting from 19 gofheparosan. In contrast to heparin, cleavage of the glycosidic bond occurred exclusively at the reducing end of GlcN to afford the GlcA-GlcN disaccharide ( Figure S4 ). We also observed that N-deacetylated heparosan was hydrolyzed very slowly under the same conditions,suggesting the importance of the N-acetyl group in this case ( Figure S5 ). Theinteresting differences in the mode of glycosidic bond cleavage between heparin and heparosan are presumably due to different stereoelectronic effects during oxocarbenium ion formation, which are possibly facilitated by the conformational flexibility of the IdoA ring. Possible explanations are provided in the Supporting Information ( Figure S6 ). Independent of the mechanism, it is fortuitous that heparin and heparosan undergo distinct cleavages to form two of the four disaccharides required for HS assembly (Figure 1) .
We envisaged that the other two disaccharides might be readily accessed through epimerization of 1 and 2.Only afew methods have been reported on epimerization as as ynthetic means to access IdoA from GlcA, and all using monosaccharides. [12] Base-or metal-catalyzed interconversion of IdoA to GlcA in 1 led to poor overall yield because of b-elimination or significant disaccharide decomposition (data not shown). Inspired by areport by Wong and colleagues, [12a] we subjected the GlcA-containing 2 to a-bromination using NBS in the presence of UV light [12a] to produce the C-5 bromo compound 5 in 75 %yield. Va rious radical initiators (AIBN,triethylborane), reducing agents (tributyltin hydride,t riphenyltin hydride), and temperatures (0-110 8 8C) were then explored to effect a-dehalogenation. We found that treatment of 5 with Et 3 Ba nd Bu 3 SnH at 20 8 8Cg ave the highest amount of epimerized IdoA-GlcN product 4 (63 %y ield), along with recovery of the valuable GlcA-GlcN epimer 2 in 31 %y ield (Scheme 2and Table S2 ). On the other hand, NBS-mediated bromination of 1 gave an epimeric mixture of the C-5 bromo compound 6.Subsequent a-dehalogenation of 6 using AIBN and Bu 3 SnH at 110 8 8Cafforded the GlcN-GlcA disaccharide 3 in 33 %y ield (Scheme 2a nd Table S3 ). Although only moderate conversion into GlcN-GlcA was observed, the GlcN-IdoA building block 1 could be recovered in 62 %yield and readily recycledt op roduce more of the GlcN-GlcA building block. Thus,t his approach provides novel streamlined routes to all four of the core HS disaccharide modules (1-4;F igure 1).
Thea ssembly of HS oligosaccharides with defined sulfation sequences requires orthogonally protected disaccharides bearing functionalities that can be selectively removed to unmask hydroxy or amino groups for sulfation. We therefore sought to synthesize strategically protected building blocks from the core disaccharides.Disaccharide 1bwas treated with ZnI 2 and TMSSPh to give the corresponding thioglycoside 7 in 88 %yield (Scheme 3a). After global deacetylation, the 6-O-and 4-O-hydroxy groups of GlcN were protected with a(2naphthyl)methylene acetal to afford compound 8.N ext, we investigated the selective 2-O-protection of IdoA, which is particularly challenging for trans-diaxial 1,2-diols.T reatment of 8 with dibutyltin oxide and benzoyl chloride at 70 8 8Cg ave the desired compound 9 as the exclusive product. Although dibutyltin oxide has been widely used for the regioselective protection of cis-1,2-and di-equatorial trans-1,2-diols, [13] to our knowledge,t his is the first successful application of dibutyltin oxide to the regioselective protection of the di-axial trans-2-O-o r3 -O-positions of IdoA. We found that 9fluorenylmethoxycarbonyl (Fmoc), 2,2,2-trichloroethoxycarbonyl (Troc), and benzoyl (Bz) groups could be selectively installed at the 2-O-position of GlcN-IdoA derivatives, whereas the monochloroacetyl (MCA)g roup could be selectively installed at the 3-O-position, highlighting the synthetic utility of this transformation (Table S4 ). Benzylation of the remaining hydroxy groups in 9 using Ag 2 Oa nd BnBr in 1:1DCM/DMF gave the valuable intermediate 10 in 
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Research Articles only nine steps (5 purifications) from heparin. Forc omparison, an analogous disaccharide containing ac yclic benzylidene acetal was synthesized by Gardiner and co-workers over 17 steps in the shortest route to date ( Figure S1 ). [4m,n] Disaccharide 10 is ahighly versatile intermediate that can be used to synthesize various simple to highly complex HS oligosaccharides.F or example,r egioselective opening of the Naph acetal would lead to a6 -O-(2-naphthyl)methyl (Nap) ether group and unmask the 4-O hydroxy group,p roviding ag lycosyl acceptor for HS chain elongation. Here,w ec hose to convert disaccharide 10 into the highly differentially protected disaccharide donor 13 and acceptor 18 as general building blocks for the synthesis of various HS sulfation motifs.T hese building blocks have five O-protecting groups (tert-butyldiphenylsilyl (TBDPS), levulinoyl (Lev), Nap, Fmoc and CO 2 t-Bu) and two N-protecting groups (N 3 , Ntrifluoroacetyl (TFA)), whose orthogonality is well documented. [4b,14] This overall strategy maximizes the number of possible sulfation patterns from each disaccharide,e nabling the generation of up to 64 different sulfation sequences from asingle protected tetrasaccharide.
Ther equired disaccharide donor 13 was synthesized by exchanging the 2-O-Bz group of 10 for aLev group,removal of the Naph acetal, and protection of the resulting primary and secondary hydroxy groups with TBDPS and Bz groups, respectively.T og enerate the disaccharide acceptor 18,t he azido group of 10 was reduced and the resulting amine protected with aT FA group to afford 14 in 81 %y ield over two steps (Scheme 3b). Glycosylation of 14 using tert-butyl 2hydroxyacetate gave compound 15 with aversatile linker [15] at the reducing end. Chemoselective deprotection of the 2-O-Bz group in 15,f ollowed by Fmoc protection of the resultant secondary alcohol and regioselective opening of the Naph acetal, gave the desired acceptor 18 in 72 %y ield. The differentially protected disaccharides 19 and 20 were also successfully synthesized using similar reaction sequences (Schemes 3c,S 1, and S2). In the future,o rthogonally protected GlcN-GlcA disaccharides derived from 3 can be readily produced. Overall, strategic protection of the core disaccharides 1/1bwith different sets of protecting groups was accomplished to provide key HS/heparin disaccharide building blocks in only 5-11 steps.
With the disaccharides in hand, we sought to generate ah ighly orthogonally protected tetrasaccharide that could serve as a" universal" building block for the generation of many sulfation sequences.Surprisingly,glycosylation of donor 19 with model acceptor 20 gave the undesired b-anomer,a s determined by HMQC and NOE analysis (Scheme S3). Although participation of the axially oriented 3-O-Ac moiety of 19 following anomeric activation could promote the observed b-selectivity,e xchanging the 3-O-Ac with an OBn group did not alter the glycosylation selectivity (data not shown). Therefore,w er easoned that the Fmoc carbonate group may not provide strong enough neighboring group participation to overcome the intrinsic b-selectivity of the glycosylation reaction, which prompted us to examine the 2-O-Lev ester protected donor 13.R eaction of donor 13 with acceptor 18 using NIS and AgOTf at room temperature delivered tetrasaccharide 21 with exclusively the desired astereochemistry ( 1 J CÀH = 174.3 Hz) in 60 %y ield, in addition to 18 %recovery of unreacted acceptor 18 (Scheme 4a). Thus, the new methods reported herein have enabled the synthesis of the uniquely designed, highly orthogonally protected HS tetrasaccharide 21,w ith seven different protecting groups (TBDPS,L ev,N ap,F moc, CO 2 t-Bu, N 3 ,a nd TFA) and differentiation of the two nitrogen atoms,ino nly 21 steps.
We next demonstrated the orthogonality of the Oprotecting groups in tetrasaccharide 21.S elective removal of the TBDPS or Nap group was achieved using HF·Py or DDQ,r espectively,t ogive compounds 22 and 23 (Scheme 4b). Alternatively,t he Lev or Fmoc groups could be chemoselectively removed using hydrazine acetate or piperidine,respectively,toafford compounds 24 and 25.T oprovide ac arboxylic acid handle for potential attachment to as olid support, the t-Bu ester at the reducing end was selectively hydrolyzed using 3% TFAi nD CM to obtain compound 26. Thus,each 2-O-, 6-O,oramino group in 21 can be selectively unmasked for regioselective sulfation, allowing in principle for the production of 64 different sulfation motifs from asingle,universal tetrasaccharide building block.
To demonstrate the versatility of 21,w eg enerated tetrasaccharides with regiodefined sulfation patterns.S ulfation of the free hydroxy groups in 22 and 25 using sulfur trioxide triethylamine complex gave the 6-O-a nd 2-Omonosulfated tetrasaccharides 27 and 28,r espectively (Scheme 5). These results confirm that all of the protecting groups (TBDPS,Nap,Lev,Fmoc,N 3 ,and TFA) remain intact under typical sulfation conditions and that our approach can allow for regioselective sulfation of the 2-O-, 6-O-, and Npositions of tetrasaccharide 21.D eprotection of the TBDPS group of 28,g lobal ester and trifluoroacetamide hydrolysis using LiOH, and acetylation of the resultant primary amine provided compound 29.S ubsequent hydrogenolysis of the benzyl and Nap groups with concomitant reduction of the N 3 group and chemoselective N-sulfation delivered the defined sulfated tetrasaccharide 30. On the other hand, treatment of 27 with thioacetic acid accomplished the one-pot conversion of the azide into the acetamide to give compound 31.Global hydrolysis,followed by hydrogenolysis and chemoselective Nsulfation as before,d elivered the desired sulfated compound 32.T hus,t etrasaccharide 21 can serve as av ersatile intermediate for the synthesis of HS GAGs displaying different regiodefined sulfation patterns.I ti sw orth noting that Scheme 4. Au niversal tetrasaccharide building block for the generation of diverse HS sequences. a) Assemblyo ft he strategically protected tetrasaccharide 21.b )Demonstrationo ft he orthogonality of the TBDPS, Nap, Lev,F moc, and t-Bu protecting groups. DDQ = 2,3dichloro-5,6-dicyano-p-benzoquinone. structures such as 30 and 32 bearing distinct O-sulfation and N-sulfation patterns on their two disaccharide units are generally more tedious to prepare chemically and are inaccessible using current chemoenzymatic methods.
Conclusion
In summary,w eh ave developed novel, concise,a nd scalable routes to obtain key HS/heparin disaccharide building blocks from natural heparin and heparosan polysaccharides.W ed emonstrate that the use of naturally derived disaccharides as minimal synthetic precursors accelerates the synthesis of HS GAGs,p roviding general and versatile disaccharide and tetrasaccharide building blocks for the assembly of HS/heparin oligosaccharides in about half the number of steps compared to traditional approaches starting from monosaccharides.Future studies will focus on obtaining large numbers of diverse,s ulfated oligosaccharides through the exploration of solid-phase synthesis methods,l ibrary encoding strategies,a nd automation. [14a, 16] Rapid access to key,u niversal HS building blocks promises to significantly expand the scope of HS synthesis,e nabling the future generation of large libraries of compounds for deciphering the sulfation code and developing new GAG-based therapies.
